Results Summary
- Quarterly revenue of $1.455
billion, exceeding midpoint of guidance.
- Quarterly GAAP earnings per diluted share of $1.89; non-GAAP earnings per diluted share of
$3.03, exceeding guidance.
- Reaffirming full-year 2025 guidance.
SUNNYVALE, Calif., Feb. 26,
2025 /PRNewswire/ -- Synopsys,
Inc. (Nasdaq: SNPS) today reported results for its first
quarter of fiscal year 2025. Revenue for the first quarter of
fiscal year 2025 was $1.455 billion,
compared to $1.511 billion for the
first quarter of fiscal year 2024.
"In Q1, Synopsys' relentless focus on execution and innovation
was evident across the business. We launched industry-leading
silicon IP and hardware-assisted verification solutions while
expanding generative AI capabilities in EDA," said Sassine Ghazi, president and CEO of Synopsys.
"We are continuing to see strong design activity at advanced nodes,
fueled by the AI-driven reinvention of compute. As the pace and
complexity of technology innovation increases, new
silicon-to-systems design paradigms are essential, and Synopsys is
well-positioned to deliver."
"We delivered a solid start to the year, with non-GAAP earnings
above guidance, and revenue in the upper end of our guided range,"
said Shelagh Glaser, CFO of
Synopsys. "These results are a product of our resilient business
model, strong operational execution, and leading technology that is
mission-critical to customers. We are reaffirming our full-year
guidance including expectations for double-digit revenue
growth."
Continuing Operations
On September 30, 2024, Synopsys completed the sale
of its Software Integrity business. Unless otherwise noted,
Synopsys' Software Integrity business has been presented as a
discontinued operation in the Synopsys' consolidated financial
statements for all periods presented herein and all financial
results and targets are presented herein on a continuing operations
basis.
GAAP Results
On a U.S. generally accepted accounting
principles (GAAP) basis, net income for the first quarter of fiscal
year 2025 was $295.7 million, or
$1.89 per diluted share, compared to
$437.5 million, or $2.82 per diluted share, for the first
quarter of fiscal year 2024.
Non-GAAP Results
On a non-GAAP basis, net income for
the first quarter of fiscal year 2025 was $473.2 million, or $3.03 per diluted share, compared to non-GAAP net
income of $525.5 million, or
$3.38 per diluted share, for the
first quarter of fiscal year 2024.
For a reconciliation of net income, earnings per diluted share
and other measures on a GAAP and non-GAAP basis, see "GAAP to
Non-GAAP Reconciliation" in the accompanying tables below.
Business Segments
Synopsys reports revenue and
operating income in two segments: (1) Design Automation, which
includes our advanced silicon design, verification products and
services, system integration products and services, digital, custom
and field programmable gate array IC design software, verification
software and hardware products, manufacturing software products and
other and (2) Design IP, which includes our interface, foundation,
security, and embedded processor IP, IP subsystems, and IP
implementation services.
Financial Targets
Synopsys also provided its
consolidated financial targets for the second quarter and full
fiscal year 2025. These targets reflect a change in Synopsys'
fiscal year from a 52/53-week period ending on the Saturday nearest
to October 31 of each year to
October 31 of each year. As a result
of this change, there will be ten fewer days in the first half of
fiscal year 2025 and two extra days in the second half of fiscal
year 2025, which results in eight fewer days in the aggregate in
Synopsys' fiscal year 2025 as compared to its fiscal year 2024.
These targets also assume no further changes to export control
restrictions or the current U.S. government "Entity List"
restrictions. These targets constitute forward-looking statements
and are based on current expectations. For a discussion of factors
that could cause actual results to differ materially from these
targets, see "Forward-Looking Statements" below.
Second Quarter and
Full Fiscal Year 2025 Financial Targets (1)
|
(in millions except
per share amounts)
|
|
|
|
|
|
|
|
Range for
Three Months Ending
|
|
Range for Fiscal
Year Ending
|
|
April 30,
2025
|
|
October 31,
2025
|
|
Low
|
High
|
|
Low
|
High
|
Revenue
|
$
1,585
|
$
1,615
|
|
$
6,745
|
$
6,805
|
GAAP
Expenses
|
$
1,191
|
$
1,211
|
|
$
4,972
|
$
5,029
|
Non-GAAP
Expenses
|
$
985
|
$
995
|
|
$
4,045
|
$
4,085
|
Non-GAAP Interest and
Other Income (Expense), net
|
$
24
|
$
26
|
|
$
94
|
$
98
|
Non-GAAP Tax
Rate
|
16 %
|
16 %
|
|
16 %
|
16 %
|
Outstanding Shares
(fully diluted)
|
156
|
158
|
|
157
|
159
|
GAAP EPS
|
$
2.21
|
$
2.33
|
|
$
10.09
|
$
10.31
|
Non-GAAP EPS
|
$
3.37
|
$
3.42
|
|
$
14.88
|
$
14.96
|
Operating Cash
Flow
|
|
|
|
~$1,800
|
Free Cash
Flow(2)
|
|
|
|
~$1,600
|
Capital
Expenditures
|
|
|
|
~$170
|
|
|
|
|
|
|
(1) Targets do not
reflect the impact of any future financing transactions related to
the Ansys Merger (as defined below) or targets for the
combined company.
|
(2) Free cash flow is
calculated as cash provided from operating activities less capital
expenditures.
|
For a reconciliation of Synopsys' second quarter and fiscal year
2025 targets, including expenses, earnings per diluted share and
other measures on a GAAP and non-GAAP basis and a discussion of the
financial targets that we are not able to reconcile without
unreasonable efforts, see "GAAP to Non-GAAP Reconciliation" in the
accompanying tables below.
Earnings Call Open to Investors
Synopsys will hold a
conference call for financial analysts and investors today at
2:00 p.m. Pacific Time. A live webcast of the call will be
available on Synopsys' corporate website
at investor.synopsys.com. Synopsys uses its website as a tool
to disclose important information about Synopsys and comply with
its disclosure obligations under Regulation Fair Disclosure. A
webcast replay will also be available on the corporate website from
approximately 5:30 p.m. Pacific Time
today through the time Synopsys announces its results for the
second quarter of fiscal year 2025 in May 2025.
Effectiveness of Information
The targets included in
this press release, the statements made during the earnings
conference call, the information contained in the financial
supplement and the corporate overview presentation, each of which
are available on Synopsys' corporate website at
www.synopsys.com (collectively, the "Earnings
Materials"), represent Synopsys' expectations and beliefs
as of February 26, 2025. Although
these Earnings Materials will remain available on Synopsys' website
through the date of the earnings call for the second quarter of
fiscal year 2025, their continued availability through such date
does not mean that Synopsys is reaffirming or confirming their
continued validity. Synopsys undertakes no duty and does not intend
to update any forward-looking statement, whether as a result of new
information or future events, or otherwise update, the targets
given in this press release unless required by law.
Availability of Final Financial Statements
Synopsys
will include final financial statements for the first quarter of
fiscal year 2025 in its quarterly report on Form 10-Q to be filed
on or before March 12, 2025.
About Synopsys
Catalyzing the era of pervasive
intelligence, Synopsys, Inc. (Nasdaq: SNPS) delivers trusted and
comprehensive silicon to systems design solutions, from electronic
design automation to silicon IP and system verification and
validation. We partner closely with semiconductor and systems
customers across a wide range of industries to maximize their
R&D capability and productivity, powering innovation today that
ignites the ingenuity of tomorrow. Learn more at
www.synopsys.com.
Reconciliation of First Quarter Fiscal Year 2025 Results
The following tables reconcile the specific items excluded from
GAAP in the calculation of non-GAAP net income, earnings per
diluted share, and tax rate for the periods indicated below.
GAAP to Non-GAAP
Reconciliation of First Quarter Fiscal Year 2025
Results(1)
|
(unaudited and in
thousands, except per share amounts)
|
|
|
|
|
|
Three Months
Ended
|
|
January
31,
|
|
2025
|
|
2024
|
GAAP net income from
continuing operations attributed to Synopsys
|
$
295,683
|
|
$
437,450
|
Adjustments:
|
|
|
|
Amortization of
acquired intangible assets
|
12,596
|
|
15,601
|
Stock-based
compensation
|
186,279
|
|
165,141
|
Acquisition/divestiture related items
|
74,829
|
|
31,932
|
Gain on sale of
strategic investments
|
—
|
|
(55,077)
|
Tax
adjustments
|
(96,214)
|
|
(69,567)
|
Non-GAAP net income
from continuing operations attributed to Synopsys
|
$
473,173
|
|
$
525,480
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
January
31,
|
|
2025
|
|
2024
|
GAAP net income from
continuing operations per diluted share attributed to
Synopsys
|
$
1.89
|
|
$
2.82
|
Adjustments:
|
|
|
|
Amortization of
acquired intangible assets
|
0.08
|
|
0.10
|
Stock-based
compensation
|
1.19
|
|
1.06
|
Acquisition/divestiture related items
|
0.48
|
|
0.21
|
Gain on sale of
strategic investments
|
—
|
|
(0.35)
|
Tax
adjustments
|
(0.61)
|
|
(0.46)
|
Non-GAAP net income
from continuing operations per diluted share attributed to
Synopsys
|
$
3.03
|
|
$
3.38
|
|
|
|
|
|
|
|
|
Shares used in
computing net income per diluted share amounts:
|
156,189
|
|
155,334
|
|
|
|
|
(1) Synopsys' first
quarter of fiscal year 2025 and 2024 ended on January 31, 2025 and
February 3, 2024, respectively. For presentation purposes,
we refer to the closest calendar month end. Fiscal year 2024 was a
53-week year, which included an extra week in the first
quarter.
|
GAAP to Non-GAAP Tax
Rate Reconciliation
|
(unaudited)
|
|
|
|
Three Months
Ended
|
|
January 31,
2025
|
|
|
GAAP effective tax
rate
|
(2.2) %
|
Stock-based
compensation
|
4.3 %
|
Acquisition/divestiture related items
(1)
|
12.6 %
|
Tax adjustments
(2)
|
1.3 %
|
Non-GAAP effective tax
rate
|
16.0 %
|
|
|
(1) The adjustment is
primarily due to the capital loss on the sale of Synopsys'
ownership in OpenLight Photonics, Inc.
|
(2) The adjustments are
primarily related to the differences in the tax rate effect
of
certain deductions,
such as the deduction for foreign-derived intangible income and
credits.
|
Reconciliation of 2025 Targets
The following tables reconcile the specific items excluded from
GAAP in the calculation of non-GAAP targets for the periods
indicated below.
GAAP to Non-GAAP
Reconciliation of Second Quarter Fiscal Year 2025
Targets
|
(in thousands,
except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
Range for
Three Months Ending
|
|
|
April 30,
2025
|
|
|
Low
|
|
High
|
Target GAAP
expenses
|
|
$
1,191,000
|
|
$
1,211,000
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
|
(12,000)
|
|
(15,000)
|
Stock-based
compensation
|
|
(194,000)
|
|
(201,000)
|
Target non-GAAP
expenses
|
|
$
985,000
|
|
$
995,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range for Three
Months Ending
|
|
|
April 30,
2025
|
|
|
Low
|
|
High
|
Target GAAP earnings
per diluted share attributed to Synopsys
|
|
$
2.21
|
|
$
2.33
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
|
0.10
|
|
0.08
|
Stock-based
compensation
|
|
1.28
|
|
1.24
|
Acquisition/divestiture related items (1)
|
|
0.08
|
|
0.06
|
Tax
adjustments
|
|
(0.30)
|
|
(0.29)
|
Target non-GAAP
earnings per diluted share attributed to Synopsys
|
|
$
3.37
|
|
$
3.42
|
|
|
|
|
|
Shares used in non-GAAP
calculation (midpoint of target range)
|
|
157,000
|
|
157,000
|
GAAP to Non-GAAP
Reconciliation of Full Fiscal Year 2025 Targets
|
(in thousands,
except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
Range for Fiscal
Year Ending
|
|
|
October 31,
2025
|
|
|
Low
|
|
High
|
Target GAAP
expenses
|
|
$
4,971,681
|
|
$
5,028,681
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
|
(46,000)
|
|
(51,000)
|
Stock-based
compensation
|
|
(820,000)
|
|
(832,000)
|
Acquisition/divestiture related items (1)
|
|
(60,681)
|
|
(60,681)
|
Target non-GAAP
expenses
|
|
$
4,045,000
|
|
$
4,085,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range for Fiscal
Year Ending
|
|
|
October 31,
2025
|
|
|
Low
|
|
High
|
Target GAAP earnings
per diluted share attributed to Synopsys
|
|
$
10.09
|
|
$
10.31
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
|
0.32
|
|
0.29
|
Stock-based
compensation
|
|
5.27
|
|
5.19
|
Acquisition/divestiture related items (1)
|
|
0.70
|
|
0.66
|
Tax
adjustments
|
|
(1.50)
|
|
(1.49)
|
Target non-GAAP
earnings per diluted share attributed to Synopsys
|
|
$
14.88
|
|
$
14.96
|
|
|
|
|
|
Shares used in non-GAAP
calculation (midpoint of target range)
|
|
158,000
|
|
158,000
|
|
|
|
|
|
(1) Adjustments
reflect actual expenses incurred by Synopsys as of January 31, 2025
or certain contractually
obligated financing fees and related amortization expenses, and do
not fully reflect all potential adjustments
for future periods for the reasons set forth in "GAAP to Non-GAAP
Reconciliation" below.
|
Forward-Looking Statements
This press release and the
investor conference call contain forward-looking statements,
including, but not limited to, statements regarding short-term and
long-term financial targets, expectations and objectives including,
among others, our long-term financial objectives, which include the
anticipated effects of our pending acquisition of ANSYS, Inc. (the
Ansys Merger); our products, technology and services; business and
market outlook, opportunities, strategies and technological trends,
such as artificial intelligence (AI); planned acquisitions and
their expected impact, such as the Ansys Merger; planned
dispositions and their expected impact; the potential impact of the
uncertain macroeconomic environment on our financial results,
including, but not limited to, the effects of sustained global
inflationary pressures and elevated interest rates, potential
economic slowdowns or recessions, supply chain disruptions,
geopolitical pressures, including, among others, the unknown impact
of current and future U.S. and foreign trade regulations,
government actions and regulatory changes, such as export control
restrictions and tariffs, and regional or global military
conflicts, and fluctuations in foreign exchange rates, and
associated global economic conditions; customer demand and market
expansion; our planned product releases and capabilities; industry
growth rates; the expected realization of our contracted but
unsatisfied or partially unsatisfied performance obligations
(backlog); software trends; planned stock repurchases; our expected
tax rate; and the impact and result of pending legal, regulatory,
administrative and tax proceedings. These statements involve risks,
uncertainties and other factors that could cause our actual
results, time frames or achievements to differ materially from
those expressed or implied in such forward-looking statements. Such
risks, uncertainties and factors include, but are not limited to:
macroeconomic conditions and geopolitical uncertainty in the global
economy; uncertainty in the growth of the semiconductor and
electronics industries; the highly competitive industry we operate
in; actions by the U.S. or foreign governments, such as the
imposition of additional export restrictions or tariffs;
consolidation among our customers and our dependence on a
relatively small number of large customers; risks and compliance
obligations relating to the global nature of our operations;
failure to complete the Ansys Merger on the terms described in our
filings with the SEC, if at all; failure to obtain required
governmental approvals related to the Ansys Merger or the
imposition of conditions to such governmental approvals that may
have an adverse effect on us; failure to realize the benefits
expected from the Ansys Merger; and more. Additional information on
potential risks, uncertainties and other factors that could affect
Synopsys' results is included in filings we make with the SEC from
time to time, including in the sections entitled "Risk Factors" in
our latest Annual Report on Form 10-K and in our latest Quarterly
Report on Form 10-Q. The financial information contained in this
press release should be read in conjunction with the consolidated
financial statements and notes thereto included in Synopsys' most
recent reports on Forms 10-K and 10-Q, each as may be amended from
time to time. Synopsys' financial results for its first quarter of
fiscal year 2025 are not necessarily indicative of Synopsys'
operating results for any future periods. The information provided
herein is as of February 26, 2025.
Synopsys undertakes no duty to, and does not intend to, update any
forward-looking statement, whether as a result of new information,
future events or otherwise, unless required by law.
SYNOPSYS,
INC.
|
Unaudited Condensed
Consolidated Statements of Income (1)
|
(in thousands,
except per share amounts)
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
January
31,
|
|
2025
|
|
2024
|
Revenue:
|
|
|
|
Time-based
products
|
$
828,238
|
|
$
805,063
|
Upfront
products
|
368,124
|
|
442,366
|
Total products revenue
|
1,196,362
|
|
1,247,429
|
Maintenance and
service
|
258,953
|
|
263,560
|
Total
revenue
|
1,455,315
|
|
1,510,989
|
Cost of
revenue:
|
|
|
|
Products
|
168,842
|
|
175,498
|
Maintenance and
service
|
92,537
|
|
90,540
|
Amortization of
acquired intangible assets
|
8,596
|
|
13,155
|
Total cost of
revenue
|
269,975
|
|
279,193
|
Gross margin
|
1,185,340
|
|
1,231,796
|
Operating
expenses:
|
|
|
|
Research and
development
|
553,216
|
|
525,534
|
Sales and
marketing
|
209,199
|
|
218,843
|
General and
administrative
|
167,086
|
|
131,264
|
Amortization of
acquired intangible assets
|
4,000
|
|
3,529
|
Total operating
expenses
|
933,501
|
|
879,170
|
Operating
income
|
251,839
|
|
352,626
|
Interest and other
income (expense), net
|
39,278
|
|
104,828
|
Income before income
taxes
|
291,117
|
|
457,454
|
Provision (benefit) for
income taxes
|
(6,294)
|
|
22,909
|
Net income from
continuing operations
|
297,411
|
|
434,545
|
Income from
discontinued operations, net of income taxes
|
—
|
|
11,662
|
Net income
|
297,411
|
|
446,207
|
Less: Net income (loss)
attributed to non-controlling interest and
redeemable non-controlling interest
|
1,728
|
|
(2,905)
|
Net income attributed
to Synopsys
|
$
295,683
|
|
$
449,112
|
|
|
|
|
Net income attributed
to Synopsys
|
|
|
|
Continuing
operations
|
$
295,683
|
|
$
437,450
|
Discontinued
operations
|
—
|
|
11,662
|
Net
income
|
$
295,683
|
|
$
449,112
|
|
|
|
|
Net income per share
attributed to Synopsys - basic:
|
|
|
|
Continuing
operations
|
$
1.91
|
|
$
2.87
|
Discontinued
operations
|
—
|
|
0.08
|
Basic net income
per share
|
$
1.91
|
|
$
2.95
|
|
|
|
|
Net income per share
attributed to Synopsys - diluted:
|
|
|
|
Continuing
operations
|
$
1.89
|
|
$
2.82
|
Discontinued
operations
|
—
|
|
0.07
|
Diluted net
income per share
|
$
1.89
|
|
$
2.89
|
|
|
|
|
Shares used in
computing per share amounts:
|
|
|
|
Basic
|
154,408
|
|
152,311
|
Diluted
|
156,189
|
|
155,334
|
|
|
|
|
(1) Synopsys' first
quarter of fiscal year 2025 and 2024 ended on January 31, 2025 and
February 3, 2024, respectively.
For presentation purposes, we refer to the closest calendar month
end. Fiscal year 2024 was a 53-week year, which
included an extra week in the first quarter.
|
SYNOPSYS,
INC.
|
|
Unaudited Condensed
Consolidated Balance Sheets (1)
|
|
(in thousands,
except par value amounts)
|
|
|
|
|
|
|
|
|
|
January 31,
2025
|
|
October 31,
2024
|
|
ASSETS:
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
3,653,880
|
|
$
3,896,532
|
|
Short-term
investments
|
|
155,489
|
|
153,869
|
|
Total cash, cash equivalents and short-term investments
|
|
3,809,369
|
|
4,050,401
|
|
Accounts
receivable, net
|
|
892,647
|
|
934,470
|
|
Inventories
|
|
415,199
|
|
361,849
|
|
Prepaid and
other current assets
|
|
1,206,401
|
|
1,122,946
|
|
Total current assets
|
|
6,323,616
|
|
6,469,666
|
|
Property and equipment,
net
|
|
546,406
|
|
563,006
|
|
Operating lease
right-of-use assets, net
|
|
545,867
|
|
565,917
|
|
Goodwill
|
|
3,433,369
|
|
3,448,850
|
|
Intangible assets,
net
|
|
180,950
|
|
195,164
|
|
Deferred income
taxes
|
|
1,393,044
|
|
1,247,258
|
|
Other long-term
assets
|
|
617,837
|
|
583,700
|
|
Total assets
|
|
$
13,041,089
|
|
$
13,073,561
|
|
|
|
|
|
|
|
LIABILITIES,
REDEEMABLE NON-CONTROLLING INTEREST AND
STOCKHOLDERS' EQUITY:
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
Accounts payable
and accrued liabilities
|
|
$
938,679
|
|
$
1,163,592
|
|
Operating lease
liabilities
|
|
99,310
|
|
94,791
|
|
Deferred
revenue
|
|
1,320,605
|
|
1,391,737
|
|
Total current liabilities
|
|
2,358,594
|
|
2,650,120
|
|
Long-term operating
lease liabilities
|
|
551,507
|
|
574,065
|
|
Long-term deferred
revenue
|
|
316,178
|
|
340,831
|
|
Long-term
debt
|
|
14,220
|
|
15,601
|
|
Other long-term
liabilities
|
|
495,689
|
|
469,738
|
|
Total liabilities
|
|
3,736,188
|
|
4,050,355
|
|
Redeemable
non-controlling interest
|
|
—
|
|
30,000
|
|
Stockholders'
equity:
|
|
|
|
|
|
Preferred stock,
$0.01 par value: 2,000 shares authorized; none
outstanding
|
|
—
|
|
—
|
|
Common stock,
$0.01 par value: 400,000 shares authorized; 154,618 and
154,112
shares outstanding,
respectively
|
|
1,547
|
|
1,541
|
|
Capital in
excess of par value
|
|
1,127,181
|
|
1,211,206
|
|
Retained
earnings
|
|
9,278,950
|
|
8,984,105
|
|
Treasury stock,
at cost: 2,643 and 3,148 shares, respectively
|
|
(860,967)
|
|
(1,025,770)
|
|
Accumulated
other comprehensive income (loss)
|
|
(241,919)
|
|
(180,380)
|
|
Total Synopsys stockholders' equity
|
|
9,304,792
|
|
8,990,702
|
|
Non-controlling
interest
|
|
109
|
|
2,504
|
|
Total stockholders' equity
|
|
9,304,901
|
|
8,993,206
|
|
Total liabilities, redeemable non-controlling interest and
stockholders' equity
|
|
$
13,041,089
|
|
$
13,073,561
|
|
|
|
|
|
|
|
(1) Synopsys' first
quarter of fiscal year 2025 ended on January 31, 2025 and its
fiscal year 2024 ended on November 2, 2024,
respectively. For presentation purposes, we refer to the closest
calendar month end. Fiscal year 2024 was a 53-week year,
which included an extra week in the first quarter.
|
|
|
SYNOPSYS,
INC.
|
Unaudited Condensed
Consolidated Statements of Cash Flows (1)
|
(in
thousands)
|
|
|
|
|
|
Three Months Ended
January 31,
|
|
2025
|
|
2024
|
CASH FLOWS FROM
OPERATING ACTIVITIES:
|
|
|
|
Net income
|
$
297,411
|
|
$
446,207
|
Adjustments to
reconcile net income to net cash used in operating
activities:
|
|
|
|
Amortization and
depreciation
|
47,934
|
|
62,888
|
Reduction of operating
lease right-of-use assets
|
25,473
|
|
24,376
|
Amortization of
capitalized costs to obtain revenue contracts
|
12,466
|
|
18,726
|
Stock-based
compensation
|
186,463
|
|
180,652
|
Allowance for credit
losses
|
9,919
|
|
6,059
|
Gain on sale of
strategic investments
|
—
|
|
(55,077)
|
Amortization of bridge
financing costs
|
10,468
|
|
1,000
|
Deferred income
taxes
|
(139,075)
|
|
(101,332)
|
Other
|
186
|
|
(786)
|
Net changes in
operating assets and liabilities, net of effects from acquisitions
and dispositions:
|
|
|
|
Accounts
receivable
|
30,948
|
|
(119,571)
|
Inventories
|
(55,852)
|
|
(60,883)
|
Prepaid and other
current assets
|
(103,567)
|
|
(96,916)
|
Other long-term
assets
|
(43,494)
|
|
(72,096)
|
Accounts payable and
accrued liabilities
|
(313,651)
|
|
(266,704)
|
Operating lease
liabilities
|
(23,102)
|
|
(23,569)
|
Income
taxes
|
86,992
|
|
(117,798)
|
Deferred
revenue
|
(96,974)
|
|
87,034
|
Net cash used in
operating activities
|
(67,455)
|
|
(87,790)
|
|
|
|
|
CASH FLOWS FROM
INVESTING ACTIVITIES:
|
|
|
|
Proceeds from
maturities of short-term investments
|
19,684
|
|
24,559
|
Proceeds from sales of
short-term investments
|
16,411
|
|
—
|
Purchases of
short-term investments
|
(37,269)
|
|
(25,612)
|
Proceeds from sales of
strategic investments
|
—
|
|
55,696
|
Purchases of strategic
investments
|
(3,288)
|
|
(822)
|
Purchases of property
and equipment, net
|
(40,715)
|
|
(40,391)
|
Acquisitions, net of
cash acquired
|
—
|
|
(67,827)
|
Proceeds from business
divestiture, net of cash divested
|
23,808
|
|
—
|
Other
|
(611)
|
|
—
|
Net cash used in
investing activities
|
(21,980)
|
|
(54,397)
|
|
|
|
|
CASH FLOWS FROM
FINANCING ACTIVITIES:
|
|
|
|
Repayment of
debt
|
(1,289)
|
|
(1,303)
|
Payment of bridge
financing and term loan costs
|
—
|
|
(48,000)
|
Issuances of common
stock
|
14,417
|
|
9,483
|
Payments for taxes
related to net share settlement of equity awards
|
(124,966)
|
|
(147,330)
|
Redemption of
redeemable non-controlling interest
|
(30,000)
|
|
—
|
Net cash used in
financing activities
|
(141,838)
|
|
(187,150)
|
Effect of exchange rate
changes on cash, cash equivalents and restricted cash
|
(9,676)
|
|
9,320
|
Net change in cash,
cash equivalents and restricted cash
|
(240,949)
|
|
(320,017)
|
Cash, cash equivalents
and restricted cash, beginning of year, including cash from
discontinued operations
|
3,898,729
|
|
1,441,187
|
Cash, cash equivalents
and restricted cash, end of period, including cash from
discontinued operations
|
3,657,780
|
|
1,121,170
|
Less: Cash, cash
equivalents and restricted cash from discontinued
operations
|
—
|
|
4,962
|
Cash, cash equivalents
and restricted cash from continuing operations
|
$
3,657,780
|
|
$
1,116,208
|
|
|
|
|
|
|
|
|
(1) Synopsys' first
quarter of fiscal year 2025 and 2024 ended on January 31, 2025 and
February 3, 2024, respectively. For presentation purposes,
we refer to the closest calendar month end. Fiscal year 2024 was a
53-week year, which included an extra week in the first
quarter.
|
Synopsys provides segment information, namely revenue, adjusted
segment operating income and adjusted segment operating margin, in
accordance with Financial Accounting Standards Board Accounting
Standards Codification Topic 280, Segment Reporting. Synopsys'
chief operating decision maker ("CODM") is our Chief
Executive Officer. In evaluating our business segments, the CODM
considers the income and expenses that the CODM believes are
directly related to those segments. The CODM does not allocate
certain operating expenses managed at a consolidated level to our
business segments and, as a result, the reported operating income
and operating margin do not include these unallocated expenses as
shown in the table below. These unallocated expenses are presented
in the table below to provide a reconciliation of the total
adjusted operating income from segments to our consolidated
operating income from continuing operations:
SYNOPSYS,
INC.
|
Business Segment
Reporting (1)(2)
|
(in
millions)
|
|
|
|
|
|
Three Months
Ended
January 31, 2025
|
|
Three Months
Ended
January 31, 2024
|
|
|
Revenue by
segment
|
|
|
|
- Design
Automation
|
$
1,020.2
|
|
$
985.3
|
% of
Total
|
70.1 %
|
|
65.2 %
|
- Design IP
|
$
435.1
|
|
$
525.7
|
% of
Total
|
29.9 %
|
|
34.8 %
|
|
|
|
|
Adjusted operating
income by segment
|
|
|
|
- Design
Automation
|
$
404.7
|
|
$
359.5
|
- Design IP
|
$
126.5
|
|
$
245.7
|
|
|
|
|
Adjusted operating
margin by segment
|
|
|
|
- Design
Automation
|
39.7 %
|
|
36.5 %
|
- Design IP
|
29.1 %
|
|
46.7 %
|
Total Adjusted
Segment Operating Income Reconciliation (1)(2)
|
(in
millions)
|
|
|
|
|
|
Three Months
Ended
January 31, 2025
|
|
Three Months
Ended
January 31,
2024
|
|
|
GAAP total operating
income – as reported
|
$
251.8
|
|
$
352.6
|
Other expenses managed
at consolidated level
|
|
|
|
-Amortization of
acquired intangible assets
|
12.6
|
|
16.7
|
-Stock-based
compensation (3)
|
186.5
|
|
165.5
|
-Non-qualified
deferred compensation plan
|
19.6
|
|
39.4
|
-Acquisition/divestiture related items
(4)
|
60.7
|
|
30.9
|
Total adjusted segment
operating income
|
$
531.2
|
|
$
605.2
|
|
|
|
|
(1) Synopsys
manages the business on a long-term, annual basis, and considers
quarterly fluctuations of
revenue and profitability as normal elements of our business.
Amounts may not foot due to rounding.
|
(2) Synopsys'
first quarter of fiscal year 2025 and 2024 ended on January 31,
2025 and February 3,
2024, respectively. For
presentation purposes, we refer to the closest calendar month end.
Fiscal year
2024 was a 53-week
year, which included an extra week in the first quarter.
|
(3) The adjustment
includes non-GAAP expenses attributable to non-controlling interest
and
redeemable
non-controlling interest.
|
(4) The adjustment
excludes the amortization of bridge financing costs entered into in
connection with
the pending Ansys Merger, and certain divestiture related items
that were recorded in interest and other
income (expense), net,
in our unaudited condensed consolidated statements of
income.
|
GAAP to Non-GAAP Reconciliation
Synopsys continues to
provide all information required in accordance with GAAP but
acknowledges evaluating its ongoing operating results may not be as
useful if an investor is limited to reviewing only GAAP financial
measures. Accordingly, Synopsys presents non-GAAP financial
measures in reporting its financial results to provide investors
with an additional tool to evaluate Synopsys' operating results in
a manner that focuses on what Synopsys believes to be its core
business operations and what Synopsys uses to evaluate its business
operations and for internal budgeting and resource allocation
purposes. This press release includes non-GAAP earnings per diluted
share, non-GAAP net income and non-GAAP tax rate for the periods
presented. It also includes future estimates for non-GAAP expenses,
non-GAAP interest and other income (expense), non-GAAP tax rate,
non-GAAP earnings per diluted share and free cash flow. These
non-GAAP financial measures may be different from non-GAAP
financial measures used by other companies.
When possible, Synopsys provides a reconciliation of non-GAAP
financial measures to their most closely applicable GAAP financial
measures. Synopsys is unable to provide a full reconciliation of
certain second quarter and full fiscal year 2025 non-GAAP
financial targets to the corresponding GAAP financial measures on a
forward-looking basis because Synopsys believes that it would not
be possible for it to have the required information necessary to
quantitatively reconcile such measures with sufficient precision
without unreasonable efforts due to, among other things, the
potential variability and limited predictability of the excluded
adjustment items necessary for a full reconciliation such as
certain acquisition/divestiture related items, restructuring
charges, tax deduction variability, changes in the fair value of
non-qualified deferred compensation plan, and gains (losses) on the
sale of strategic investments. For the same reasons, Synopsys is
unable to address the probable significance of the unavailable
information.
Synopsys' management does not itself, nor does it suggest that
investors should, consider such non-GAAP financial measures in
isolation from, as superior to, or as a substitute for, financial
information prepared in accordance with GAAP. These non-GAAP
financial measures are meant to supplement, and be viewed in
conjunction with, the corresponding GAAP financial measures.
Synopsys' management believes presentation of non-GAAP financial
measures, when shown in conjunction with the corresponding GAAP
financial measures, provides useful information to investors
allowing them to view financial and business trends relating to our
financial condition and results of operations through the eyes of
management. Synopsys' management evaluates and makes decisions
about our business operations using both GAAP financial measures
and non-GAAP financial measures to help facilitate internal
comparisons to Synopsys' historical operating results and
forecasted targets, planning and forecasting in subsequent periods
and comparisons to competitors' operating results.
The following are descriptions of the adjustments made to
reconcile non-GAAP financial measures (other than free cash flow,
which is defined in the footnote to the Financial Targets
table above) to the most directly comparable GAAP financial
measures:
(i) Amortization of acquired intangible assets. We incur
expenses from amortization of acquired intangible assets, which may
include impairment charges from write-downs of acquired intangible
assets. Acquired intangible assets include, among other things,
core/developed technology, customer relationships, contract rights,
trademarks and trade names, and other intangibles related to
acquisitions. We amortize the intangible assets over their
estimated useful lives. We do not enter into acquisitions on a
predictable cycle. The amount of an acquisition's purchase price
allocated to intangible assets and their estimated useful lives can
vary significantly and are unique to each acquisition. From time to
time, we incur impairment charges due to write-downs of acquired
intangible assets. We believe that the presentation of non-GAAP
financial measures that adjust for the amortization of intangible
assets, including impairment charges, provides investors and others
with a consistent basis for comparison across accounting periods.
We also exclude this item because such expenses are non-cash in
nature and we believe the non-GAAP financial measures excluding
this item provide meaningful supplemental information regarding our
core operational performance and liquidity, and ability to invest
in research and development and fund future acquisitions and
capital expenditures.
(ii) Stock-based compensation. Stock-based compensation
expenses consist primarily of expenses related to restricted stock
units, stock options, employee stock purchase rights and other
stock awards, including such expenses associated with acquisitions.
We exclude stock-based compensation expense from our non-GAAP
financial measures primarily because it is not an expense that
typically requires or will require cash settlement by us. Further,
the expense for the fair value of the stock-based instruments we
utilize may bear little resemblance to the actual value realized
upon the vesting or future exercise of the related stock-based
awards and, therefore, is not used by management to assess the core
profitability of our business operations.
(iii) Acquisition/divestiture related items. In
connection with certain of our business combinations and/or
divestitures, we incur significant expenses that we would not have
otherwise incurred as part of our business operations. These
expenses include, among other things, compensation expenses,
professional fees and other direct expenses, concurrent
restructuring activities and divestiture activities, including
employee severance and other exit costs, bridge financing costs,
costs related to integration activities, debt forgiveness, changes
to the fair value of contingent consideration related to the
acquired company, and amortization of the fair value difference of
below-market value assets arising from arrangements entered into or
acquired in conjunction with an acquisition. We also recognize the
gains and losses from the mark-up of equity or cost method
investments to fair value upon obtaining control through
acquisition. We exclude these items because they are related to
acquisitions and divestitures and have no direct correlation to the
core operation of our business. Further, because we do not acquire
or divest businesses on a predictable cycle and the terms of each
transaction can vary significantly and are unique to each
transaction, we believe it is useful to exclude such expenses when
looking for a consistent basis for comparison across accounting
periods.
(iv) Restructuring charges. We initiate restructuring
activities to align our costs to our operating plans and business
strategies based on then-current economic conditions, and such
activities have a specific and defined term. Restructuring costs
generally include severance and other termination benefits related
to voluntary retirement programs, involuntary headcount reductions
and facilities closures. Such restructuring costs include
elimination of operational redundancy, permanent reductions in
workforce and facilities closures and, therefore, are not
considered by us to be a part of the core operation of our business
and are not used by management when assessing the core
profitability and performance of our business operations.
(v) Gains (losses) on the sale of strategic investments.
We exclude gains and losses on the sale of equity investments in
privately held companies because we do not believe they are
reflective of our core business and operating results.
(vi) Deferred compensation. We exclude changes in the
fair value of our non-qualified deferred compensation plan because
we do not use these to assess the core profitability of our
business operations.
(vii) Income tax effect of non-GAAP pre-tax adjustments.
Excluding the income tax effect of non-GAAP pre-tax adjustments
from the provision for income taxes assists investors in
understanding the tax provision associated with those adjustments
and the effect on net income. We utilize an annual non-GAAP tax
rate in calculating non-GAAP financial measures to provide better
consistency across interim reporting periods by eliminating the
effects of certain non-recurring and other period-specific items,
which can vary in size and frequency and do not necessarily reflect
our normal operations, and to more closely align our tax rate with
our expected geographic earnings mix. This annual non-GAAP tax rate
is based on an evaluation of our historical and projected mix of
U.S. and international profit before tax, taking into account the
impact of non-GAAP adjustments, U.S. tax law changes, as well as
other factors such as our current tax structure, existing tax
positions and expected recurring tax incentives. Based on these
considerations, we have elected to adopt a non-GAAP tax rate of 16%
for fiscal year 2025.
INVESTOR CONTACT:
Trey Campbell
Synopsys, Inc.
650-584-4289
Synopsys-ir@synopsys.com
EDITORIAL CONTACT:
Cara Walker
Synopsys, Inc.
650-584-5000
corp-pr@synopsys.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/synopsys-posts-financial-results-for-first-quarter-fiscal-year-2025-302386200.html
SOURCE Synopsys, Inc.